SJPA:LSE:LSE-iShares Core MSCI Japan IMI UCITS ETF USD (Acc) (GBX)

ETF | Others |

Last Closing

USD 4333

Change

+77.00 (+1.81)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.00 (-1.04%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.85 (-1.49%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.42 (+2.28%)

USD 547.46B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.26 (+1.85%)

USD 547.46B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.42%)

USD 266.08B
0QZO:LSE 0QZO

+1.20 (+1.28%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.45 (+0.87%)

USD 202.26B
PRJU:LSE Amundi Index Solutions - Amund..

+0.72 (+2.32%)

USD 200.79B
0R24:LSE Intel Corp.

-0.08 (-0.34%)

USD 196.14B

ETFs Containing SJPA:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.11% 53% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.11% 51% F 56% F
Trailing 12 Months  
Capital Gain 10.48% 40% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.48% 37% F 45% F
Trailing 5 Years  
Capital Gain 27.18% 49% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.18% 47% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 6.38% 55% F 60% D-
Dividend Return 6.38% 55% F 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.69% 67% D+ 81% B-
Risk Adjusted Return 65.83% 73% C 83% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike